|
ICL
ICL Group Ltd.
ICL · Q4 FY2024
|
Q4 FY2024 |
|
ICL Q4 FY2024 transcript
|
|
P
Everpure, Inc.
P · Q4 FY2025
|
Q4 FY2025 |
|
P Q4 FY2025 transcript
|
|
MGPI
Mgp Ingredients Inc
MGPI · Q4 FY2024
|
Q4 FY2024 |
|
MGPI Q4 FY2024 transcript
|
|
SUI
Sun Communities Inc
SUI · Q2 FY2025
|
Q2 FY2025 |
|
SUI Q2 FY2025 transcript
|
|
NVDA
Nvidia Corp
NVDA · Q4 FY2025
|
Q4 FY2025 |
|
NVDA Q4 FY2025 transcript
|
|
FWRD
Forward Air Corp
FWRD · Q4 FY2024
|
Q4 FY2024 |
|
FWRD Q4 FY2024 transcript
|
|
ALEC
Alector, Inc.
ALEC · Q4 FY2024
|
Q4 FY2024 |
|
ALEC Q4 FY2024 transcript
|
|
BKV
BKV Corp
BKV · Q4 FY2024
|
Q4 FY2024 |
|
BKV Q4 FY2024 transcript
|
|
SNPS
Synopsys Inc
SNPS · Q1 FY2025
|
Q1 FY2025 |
|
SNPS Q1 FY2025 transcript
|
|
SII
Sprott Inc.
SII · Q4 FY2024
|
Q4 FY2024 |
|
SII Q4 FY2024 transcript
|
|
NRG
Nrg Energy, Inc.
NRG · Q4 FY2024
|
Q4 FY2024 |
|
NRG Q4 FY2024 transcript
|
|
TBPH
Theravance Biopharma, Inc.
TBPH · Q4 FY2024
|
Q4 FY2024 |
|
TBPH Q4 FY2024 transcript
|
|
AIN
Albany International Corp /De/
AIN · Q4 FY2024
|
Q4 FY2024 |
|
AIN Q4 FY2024 transcript
|
|
TSHA
Taysha Gene Therapies, Inc.
TSHA · Q4 FY2024
|
Q4 FY2024 |
|
TSHA Q4 FY2024 transcript
|
|
HCAT
Health Catalyst, Inc.
HCAT · Q4 FY2024
|
Q4 FY2024 |
|
HCAT Q4 FY2024 transcript
|
|
A
Agilent Technologies, Inc.
A · Q1 FY2025
|
Q1 FY2025 |
|
A Q1 FY2025 transcript
|
|
ECPG
Encore Capital Group Inc
ECPG · Q4 FY2024
|
Q4 FY2024 |
|
ECPG Q4 FY2024 transcript
|
|
INVH
Invitation Homes Inc.
INVH · Q4 FY2024
|
Q4 FY2024 |
|
INVH Q4 FY2024 transcript
|
|
HEI
Heico Corp
HEI · Q1 FY2025
|
Q1 FY2025 |
|
HEI Q1 FY2025 transcript
|
|
CHE
Chemed Corp
CHE · Q4 FY2024
|
Q4 FY2024 |
|
CHE Q4 FY2024 transcript
|
|
CRM
Salesforce, Inc.
CRM · Q4 FY2025
|
Q4 FY2025 |
|
CRM Q4 FY2025 transcript
|
|
BCO
Brinks Co
BCO · Q4 FY2024
|
Q4 FY2024 |
|
BCO Q4 FY2024 transcript
|
|
BUD
Anheuser-Busch InBev SA/NV
BUD · Q4 FY2024
|
Q4 FY2024 |
|
BUD Q4 FY2024 transcript
|
|
MGNI
Magnite, Inc.
MGNI · Q4 FY2024
|
Q4 FY2024 |
|
MGNI Q4 FY2024 transcript
|